Emerging role of long noncoding RNAs in autoimmune diseases

Autoimmunity Reviews

Volumn 14, Issue 9, 2015, Pages 798-805

  Wu, Guo Cui ^a   Pan, Hai Feng ^a   Leng, Rui Xue ^a   Wang, De Guang ^a   Li, Xiang Pei ^a   Li, Xiao Mei ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune disease; Autoimmunity; Immune function; LncRNA; Noncoding RNA

Indexed keywords

INTERLEUKIN 7 RECEPTOR; LONG UNTRANSLATED RNA; NUCLEAR ENRICHED ABUNDANT TRANSCRIPT 1; P50 ASSOCIATED COX 2 EXTRAGENIC RNA; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; CELL MATURATION; CROHN DISEASE; DENDRITIC CELL; DERMATOMYOSITIS; GRANULOCYTE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NEXT GENERATION SEQUENCING; POLYMYOSITIS; PSORIASIS; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE; ANIMAL; AUTOIMMUNITY; GENETICS; IMMUNOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; PSORIASIS; RNA, LONG NONCODING; THYROID DISEASES; TOLL-LIKE RECEPTORS;

EID: 84938213025     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.05.004     Document Type: Review

References (93)

1. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
2. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
3. Wright M.W., Bruford E.A. Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics 2011, 5:90-98.
4. Moran V.A., Perera R.J., Khalil A.M. Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs. Nucleic Acids Res 2012, 40:6391-6400.
5. Orom U.A., Derrien T., Beringer M., Gumireddy K., Gardini A., Bussotti G., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58.
6. Sun L., Goff L.A., Trapnell C., Alexander R., Lo K.A., Hacisuleyman E., et al. Long noncoding RNAs regulate adipogenesis. Proc Natl Acad Sci U S A 2013, 110:3387-3392.
7. Singh R.P., Massachi I., Manickavel S., Singh S., Rao N.P., Hasan S., et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 2013, 12:1160-1165.
8. Jimenez S.A., Piera-Velazquez S. Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjogren's syndrome. Autoimmun Rev 2013, 12:1046-1051.
9. Kretz M., Webster D.E., Flockhart R.J., Lee C.S., Zehnder A., Lopez-Pajares V., et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev 2012, 26:338-343.
10. Kretz M., Siprashvili Z., Chu C., Webster D.E., Zehnder A., Qu K., et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 2013, 493:231-235.
11. Ying L., Huang Y., Chen H., Wang Y., Xia L., Chen Y., et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst 2013, 9:407-411.
12. Feldstein O., Nizri T., Doniger T., Jacob J., Rechavi G., Ginsberg D. The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage. Mol Cancer 2013, 12:131.
13. Wang P., Xue Y., Han Y., Lin L., Wu C., Xu S., et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation. Science 2014, 344:310-313.
14. Perkel J.M. Visiting "noncodarnia". Biotechniques 2013, 54:301. [303-4].
15. Kaikkonen M.U., Lam M.T., Glass C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011, 90:430-440.
16. Ledford H. Circular RNAs throw genetics for a loop. Nature 2013, 494:415.
17. Mercer T.R., Wilhelm D., Dinger M.E., Solda G., Korbie D.J., Glazov E.A., et al. Expression of distinct RNAs from 3' untranslated regions. Nucleic Acids Res 2011, 39:2393-2403.
18. Smemo S., Campos L.C., Moskowitz I.P., Krieger J.E., Pereira A.C., Nobrega M.A. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum Mol Genet 2012, 21:3255-3263.
19. Fang X.Y., Pan H.F., Leng R.X., Ye D.Q. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett 2015, 356:357-366.
20. Michalik K.M., You X., Manavski Y., Doddaballapur A., Zornig M., Braun T., et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 2014, 114:1389-1397.
21. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012, 22:1775-1789.
22. Ponjavic J., Ponting C.P., Lunter G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 2007, 17:556-565.
23. Schonrock N., Harvey R.P., Mattick J.S. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res 2012, 111:1349-1362.
24. Shi X., Sun M., Liu H., Yao Y., Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013, 339:159-166.
25. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
26. Jenkins K.A., Mansell A. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 2010, 49:237-244.
27. Guttman M., Amit I., Garber M., French C., Lin M.F., Feldser D., et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227.
28. Carpenter S., Aiello D., Atianand M.K., Ricci E.P., Gandhi P., Hall L.L., et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013, 341:789-792.
29. Szmyrka-Kaczmarek M., Kosmaczewska A., Ciszak L., Szteblich A., Wiland P. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus. Postepy Hig Med Dosw (Online) 2014, 68:893-898.
30. Naganuma T., Nakagawa S., Tanigawa A., Sasaki Y.F., Goshima N., Hirose T. Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J 2012, 31:4020-4034.
31. Imamura K., Imamachi N., Akizuki G., Kumakura M., Kawaguchi A., Nagata K., et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell 2014, 53:393-406.
32. Hirose T., Virnicchi G., Tanigawa A., Naganuma T., Li R., Kimura H., et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol Biol Cell 2014, 25:169-183.
33. Cui H., Xie N., Tan Z., Banerjee S., Thannickal V.J., Abraham E., et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur J Immunol 2014, 44:2085-2095.
34. Krawczyk M., Emerson B.M. p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-kappaB complexes. Elife 2014, 3. e01776.
35. Itoi S., Tanemura A., Tsuji C., Kitaba S., Yokomi A., Katayama I., et al. A rare case of male bullous lupus erythematosus complicated with subsequent annular hypopigmentation. Case Rep Dermatol 2014, 6:91-97.
36. Mao A.P., Shen J., Zuo Z. Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages. BMC Genomics 2015, 16:45.
37. Steinman R.M., Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006, 311:17-58.
38. Schmidt S.V., Nino-Castro A.C., Schultze J.L. Regulatory dendritic cells: there is more than just immune activation. Front Immunol 2012, 3:274.
39. Artis D., Spits H. The biology of innate lymphoid cells. Nature 2015, 517:293-301.
40. Zhang X., Lian Z., Padden C., Gerstein M.B., Rozowsky J., Snyder M., et al. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 2009, 113:2526-2534.
41. Zhang X., Weissman S.M., Newburger P.E. Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells. RNA Biol 2014, 11:777-787.
42. Mourtada-Maarabouni M., Hedge V.L., Kirkham L., Farzaneh F., Williams G.T. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5. J Cell Sci 2008, 121:939-946.
43. Mourtada-Maarabouni M., Hasan A.M., Farzaneh F., Williams G.T. Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). Mol Pharmacol 2010, 78:19-28.
44. Williams G.T., Mourtada-Maarabouni M., Farzaneh F. A critical role for non-coding RNA GAS5 in growth arrest and rapamycin inhibition in human T-lymphocytes. Biochem Soc Trans 2011, 39:482-486.
45. Gomez J.A., Wapinski O.L., Yang Y.W., Bureau J.F., Gopinath S., Monack D.M., et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell 2013, 152:743-754.
46. Collier S.P., Collins P.L., Williams C.L., Boothby M.R., Aune T.M. Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol 2012, 189:2084-2088.
47. Vigneau S., Rohrlich P.S., Brahic M., Bureau J.F. Tmevpg1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J Virol 2003, 77:5632-5638.
48. Collier S.P., Henderson M.A., Tossberg J.T., Aune T.M. Regulation of the Th1 genomic locus from Ifng through Tmevpg1 by T-bet. J Immunol 2014, 193:3959-3965.
49. Hu G., Tang Q., Sharma S., Yu F., Escobar T.M., Muljo S.A., et al. Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol 2013, 14:1190-1198.
50. Ranzani V., Rossetti G., Panzeri I., Arrigoni A., Bonnal R.J., Curti S., et al. The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4. Nat Immunol 2015, 16:318-325.
51. Verma-Gaur J., Torkamani A., Schaffer L., Head S.R., Schork N.J., Feeney A.J. Noncoding transcription within the Igh distal V(H) region at PAIR elements affects the 3D structure of the Igh locus in pro-B cells. Proc Natl Acad Sci U S A 2012, 109:17004-17009.
52. Cope A.P., Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Curr Opin Immunol 2004, 16:780-786.
53. Chatenoud L. Immune therapies of autoimmune diseases: are we approaching a real cure?. Curr Opin Immunol 2006, 18:710-717.
54. Pan H.F., Li X.P., Zheng S.G., Ye D.Q. Emerging role of interleukin-22 in autoimmune diseases. Cytokine Growth Factor Rev 2013, 24:51-57.
55. Kunz M., Ibrahim S.M. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009, 2009:979258.
56. Mahler M., Fritzler M.J., Satoh M. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen. Autoimmun Rev 2015, 14:254-257.
57. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
58. Borchers A.T., Leibushor N., Naguwa S.M., Cheema G.S., Shoenfeld Y., Gershwin M.E. Lupus nephritis: a critical review. Autoimmun Rev 2012, 12:174-194.
59. Suarez-Gestal M., Calaza M., Endreffy E., Pullmann R., Ordi-Ros J., Sebastiani G.D., et al. Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther 2009, 11:R69.
60. Kino T., Hurt D.E., Ichijo T., Nader N., Chrousos G.P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 2010, 3:ra8.
61. Haywood M.E., Rose S.J., Horswell S., Lees M.J., Fu G., Walport M.J., et al. Overlapping BXSB congenic intervals, in combination with microarray gene expression, reveal novel lupus candidate genes. Genes Immun 2006, 7:250-263.
62. Koenders M.I., van den Berg W.B. Novel therapeutic targets in rheumatoid arthritis. Trends Pharmacol Sci 2015, 36:189-195.
63. Yamanaka H. TNF as a target of inflammation in rheumatoid arthritis. Endocr Metab Immune Disord Drug Targets 2015, 10.2174/1871530315666150316121808.
64. Harrison P., Pointon J.J., Chapman K., Roddam A., Wordsworth B.P. Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:1768-1770.
65. Solus J.F., Chung C.P., Oeser A., Li C., Rho Y.H., Bradley K.M., et al. Genetics of serum concentration of IL-6 and TNFalpha in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis. Clin Rheumatol 2015, 10.1007/s10067-015-2881-6.
66. Song J., Kim D., Han J., Kim Y., Lee M., Jin E.J. PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med 2015, 15:121-126.
67. Stuhlmuller B., Kunisch E., Franz J., Martinez-Gamboa L., Hernandez M.M., Pruss A., et al. Detection of oncofetal h19 RNA in rheumatoid arthritis synovial tissue. Am J Pathol 2003, 163:901-911.
68. Fu Z., Gilbert E.R., Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 2013, 9:25-53.
69. He B., Li X., Yu H., Zhou Z. Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus. J Diabetes 2015, 10.1111/1753-0407.
70. Estrada-Capetillo L., Hernandez-Castro B., Monsivais-Urenda A., Alvarez-Quiroga C., Layseca-Espinosa E., Abud-Mendoza C., et al. Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol 2013, 2013:584303.
71. Guan Y., Kuo W.L., Stilwell J.L., Takano H., Lapuk A.V., Fridlyand J., et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 2007, 13:5745-5755.
72. Millis M.P., Bowen D., Kingsley C., Watanabe R.M., Wolford J.K. Variants in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes. Diabetes 2007, 56:3027-3032.
73. Hakonarson H., Grant S.F., Bradfield J.P., Marchand L., Kim C.E., Glessner J.T., et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007, 448:591-594.
74. Todd J.A., Walker N.M., Cooper J.D., Smyth D.J., Downes K., Plagnol V., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864.
75. Plagnol V., Howson J.M., Smyth D.J., Walker N., Hafler J.P., Wallace C., et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011, 7. e1002216.
76. Wallace C., Smyth D.J., Maisuria-Armer M., Walker N.M., Todd J.A., Clayton D.G. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 2010, 42:68-71.
77. Burfoot R.K., Jensen C.J., Field J., Stankovich J., Varney M.D., Johnson L.J., et al. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 2008, 71:42-50.
78. Dong Y.H., Fu D.G. Autoimmune thyroid disease: mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci 2014, 18:3611-3618.
79. Shirasawa S., Harada H., Furugaki K., Akamizu T., Ishikawa N., Ito K., et al. SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet 2004, 13:2221-2231.
80. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N Engl J Med 2009, 361:496-509.
81. Roberson E.D., Bowcock A.M. Psoriasis genetics: breaking the barrier. Trends Genet 2010, 26:415-423.
82. Sonkoly E., Bata-Csorgo Z., Pivarcsi A., Polyanka H., Kenderessy-Szabo A., Molnar G., et al. Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. J Biol Chem 2005, 280:24159-24167.
83. Bari L., Bacsa S., Sonkoly E., Bata-Csorgo Z., Kemeny L., Dobozy A., et al. Comparison of stress-induced PRINS gene expression in normal human keratinocytes and HaCaT cells. Arch Dermatol Res 2011, 303:745-752.
84. Szegedi K., Goblos A., Bacsa S., Antal M., Nemeth I.B., Bata-Csorgo Z., et al. Expression and functional studies on the noncoding RNA, PRINS. Int J Mol Sci 2012, 14:205-225.
85. Szegedi K., Sonkoly E., Nagy N., Nemeth I.B., Bata-Csorgo Z., Kemeny L., et al. The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS. Exp Dermatol 2010, 19:269-278.
86. Holm S.J., Sanchez F., Carlen L.M., Mallbris L., Stahle M., O'Brien K.P. HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3. Acta Derm Venereol 2005, 85:2-8.
87. Chang Y.T., Chou C.T., Shiao Y.M., Lin M.W., Yu C.W., Chen C.C., et al. Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes. Br J Dermatol 2006, 155:663-669.
88. Lega J.C., Fabien N., Reynaud Q., Durieu I., Durupt S., Dutertre M., et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 2014, 13:883-891.
89. Dau P.C. Plasma exchange in polymyositis and dermatomyositis. N Engl J Med 1992, 327:1030-1031.
90. Venalis P., Lundberg I.E. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology (Oxford) 2014, 53:397-405.
91. Satoh T., Okano T., Matsui T., Watabe H., Ogasawara T., Kubo K., et al. Novel autoantibodies against 7SL RNA in patients with polymyositis/dermatomyositis. J Rheumatol 2005, 32:1727-1733.
92. Baumgart D.C., Sandborn W.J. Crohn's disease. Lancet 2012, 380:1590-1605.
93. Qiao Y.Q., Huang M.L., Xu A.T., Zhao D., Ran Z.H., Shen J. LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn's disease. J Biomed Sci 2013, 20:87.